Lindian Secures Binding Monazite Offtake for Kangankunde

Binding Volumes Cover Both Expansion Stages

Lindian Resources said its Singapore subsidiary, Lindian Global Rare Earths, executed a binding offtake term sheet with an unnamed major rare-earths refining group for 30,000 dry metric tonnes of monazite concentrate from the Kangankunde Rare Earths Project. The commitment covers 10,000 dmt for Stage 1 and 20,000 dmt per annum for Stage 2. First shipments are planned from Nacala Port in January 2027, followed by monthly deliveries.

The company announced the agreement on November 9, 2026. The counterparty, purchase price and final contract value were not disclosed in the reviewed material. The document is a binding term sheet rather than a full-form offtake agreement, and the remaining conditions need to be finalized before the commercial structure can be treated as fully contracted revenue.

Allocation Extends Beyond Stage 1

Lindian said Stage 2 allocation now stands at 45,000 dmt per annum. That figure combines the 20,000 dmt per annum covered by the new term sheet with up to 25,000 dmt per annum subject to Iluka Resources’ right of first refusal for Stage 2 expansion volumes. The company also cited previously announced offtake agreements with Iluka in Australia and Carester in France as contributing to a geographically diversified customer base.

The distinction matters for the development case: the new term sheet secures 30,000 dmt across Stage 1 and Stage 2, while the larger 45,000 dmt Stage 2 figure includes an existing right of first refusal rather than 45,000 dmt under the new binding term sheet.

Refining Link Targets Magnetic Revenue

The proposed buyer is described as a rare-earths refining group with established rare-earth chloride and solvent-extraction operations. That position links Kangankunde’s concentrate to downstream separation rather than merely establishing an interest in the raw mineral.

Lindian said the concentrate carries an average 54% total rare earth oxide grade, with a 52% minimum, and is priced against the Asian Metals Index with adjustments for rare-earth oxide payability. Freight and insurance are included, and the buyer is to pay invoices through a commercial bank letter of credit issued before shipment. The reported specifications also identify no deleterious elements and low levels of uranium and thorium.

The pricing basket covers ten rare-earth elements. Neodymium, praseodymium, dysprosium and terbium are expected to generate most product revenue, according to Lindian. That creates an explicit exposure to magnetic rare-earth oxide prices rather than a guarantee of fixed revenue from the concentrate.

Contract Execution Remains a Key Test

The term sheet gives Lindian a clearer path to contracted revenue ahead of the project’s planned December 2026 first production, but the reporting does not establish that production has occurred or that the buyer has taken delivery. Executive Chairman Robert Martin said Stage 1 concentrate capacity was fully allocated between offtake partners and Lindian’s SARECO mixed rare-earths carbonate facility, while the company was still working toward finalizing remaining Stage 2 offtakes and selecting partners for SARECO output.

The next observable checkpoints are execution of the full offtake agreement, completion of its conditions, first production at Kangankunde and the planned January 2027 shipment. Until then, the binding term sheet supports a stronger commercial position but not realized sales.